Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
8-year follow-up of age-related long-term effects of methylphenidate on brain dopaminergic development in ADHD
NL-OMON49555Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Amsterdam University Medical Center. Started May 2021; status: active, not recruiting.
02
Drugs
methylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NL-OMON49555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49555.